Clinical Trials Directory

Trials / Unknown

UnknownNCT00892996

Efficacy of Prevention for Postoperative Nausea and Vomiting After Intrathecal Morphine in Cesarean Section

Efficacy of Prevention for Postoperative Nausea and Vomiting After Intrathecal Morphine in Cesarean Section: a Randomized Comparison of Metoclopramide or Ondansetron Alone or in the Combination With Dexamethasone.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Post-operative nausea and vomiting are the major complications after spinal anesthesia with intrathecal morphine, therefore antiemetic drugs should be administered for best satisfaction of anesthesia to prevent these complication. Furthermore, administration of a combination of antiemetic drugs with different mechanisms of action appears reasonable and synergistic effect of drugs. In conclusion, we study efficacy of antiemetic effect of single antiemetic drug compare with combination antiemetic drugs.

Detailed description

In this study : a randomized, double-blind, placebo-controlled, clinical trial comparing single doses of Metoclopramide 10 mg and Ondansetron 8 mg alone and a combination of Dexamethasone 5 mg and Metoclopramide 10 mg or a combination of Dexamethasone 5 mg and Ondansetron 8 mg for prevention of PONV after spinal morphine for cesarean section. Inclusion criteria 1. Patient undergoes elective cesarean section age more than 18 years 2. Patient accepted in spinal anesthesia technique 3. ASA classification I-II 4. Patient understand question and evaluation process Exclusion criteria 1. Hyperemesis gravidarum 2. Patient with ongoing antiemetic drugs treatment 3. Patient with history of drug allergy in Metoclopramide,Ondansetron and Dexamethasone Outcome measurement By oral interview and nurse notification in 24 hr. post-operatively. Detail of outcome measurement 1. Nausea and vomiting score 2. Pain score 3. Sedation score 4. Itch symptom 5. Patient satisfaction

Conditions

Interventions

TypeNameDescription
DRUGdexamethasoneMetoclopramide 10 mg and dexamethasone 5 mg intravenous
DRUGdexamethasone 5 mgOndansetron 8 mg and dexamethasone 5 mg IV

Timeline

Start date
2009-05-01
Primary completion
2010-04-01
Completion
2011-04-01
First posted
2009-05-05
Last updated
2009-05-05

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT00892996. Inclusion in this directory is not an endorsement.